Mesenchymal stromal cells are more effective than their extracellular vesicles at reducing lung injury regardless of acute respiratory distress syndrome etiology

Stem Cells International

Volumn 2019, Issue , 2019, Pages

  Silva, Johnatas D ^a,b   De Castro, Ligia L ^a,b   Braga, Cassia L ^a   Oliveira, Gisele P ^a   Trivelin, Stefano A ^a   Barbosa Junior, Carlos M ^a   Morales, Marcelo M ^a,b   Dos Santos, Claudia C ^c   Weiss, Daniel J ^d   Lopes Pacheco, Miquéias ^a   Cruz, Fernanda F ^a   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b National Institute for Science and Technology Translational Medicine   (Brazil)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATELECTASIS; CELL DENSITY; CELL ISOLATION; CELL VIABILITY; COLLAGEN FIBER; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; LUNG COMPLIANCE; LUNG EDEMA; LUNG HOMOGENATE; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MACROPHAGE; MALE; MESENCHYMAL STROMA CELL; MOUSE; NEUTROPHIL COUNT; NONHUMAN; TREATMENT RESPONSE;

EID: 85072207910     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2019/8262849     Document Type: Article

References (48)

1. Bein T., Grasso S., Moerer O., Quintel M., Guerin C., Deja M., Brondani A., Mehta S., The standard of care of patients with ARDS: ventilatory settings and rescue therapies for refractory hypoxemia. Intensive Care Medicine 2016 42 5 699 711 10.1007/s00134-016-4325-4 2-s2.0-84962160969 27040102 Intensive Care Medicine, vol. 42, no. 5, pp. 699â€"711, 2016.
2. Bellani G., Laffey J. G., Pham T., Fan E., Brochard L., Esteban A., Gattinoni L., van Haren F., Larsson A., McAuley D., Ranieri M., Rubenfeld G., Thompson B. T., Wrigge H., Slutsky A. S., Pesenti A., LUNG SAFE Investigators, ESICM Trials Group, Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016 315 8 788 800 10.1001/jama.2016.0291 2-s2.0-84959277025 26903337 JAMA, vol. 315, no. 8, pp. 788â€"800, 2016.
3. Biehl M., Kashyap R., Ahmed A. H., Reriani M. K., Ofoma U. R., Wilson G. A., Li G., Malinchoc M., Sloan J. A., Gajic O., Six-month quality-of-life and functional status of acute respiratory distress syndrome survivors compared to patients at risk: A population-based study. Critical Care 2015 19 1 10.1186/s13054-015-1062-y 2-s2.0-84942636659 Critical Care, vol. 19, no. 1, 2015.
4. Duggal A., Ganapathy A., Ratnapalan M., Adhikari N. K., Pharmacological treatments for acute respiratory distress syndrome: systematic review. Minerva Anestesiologica 2015 81 567 588 Minerva Anestesiologica, vol. 81, pp. 567â€"588, 2015.
5. Cruz F. F., Weiss D. J., Rocco P. R. M., Prospects and progress in cell therapy for acute respiratory distress syndrome. Expert Opinion on Biological Therapy 2016 16 11 1353 1360 10.1080/14712598.2016.1218845 2-s2.0-84989352079 Expert Opinion on Biological Therapy, vol. 16, no. 11, pp. 1353â€"1360, 2016.
6. Hayes M., Curley G. F., Masterson C., Devaney J., O'Toole D., Laffey J. G., Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury. Intensive Care Medicine Experimental 2015 3 1 10.1186/s40635-015-0065-y Intensive Care Medicine Experimental, vol. 3, no. 1, 2015.
7. Antunes M. A., Abreu S. C., Cruz F. F., Teixeira A. C., Lopes-Pacheco M., Bandeira E., Olsen P. C., Diaz B. L., Takyia C. M., Freitas I. P. R. G., Rocha N. N., Capelozzi V. L., Xisto D. G., Weiss D. J., Morales M. M., Rocco P. R. M., Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respiratory Research 2014 15 1 118 10.1186/s12931-014-0118-x 2-s2.0-84907510672 25272959 Respiratory Research, vol. 15, no. 1, p. 118, 2014.
8. Curley G. F., Hayes M., Ansari B., Shaw G., Ryan A., Barry F., O'Brien T., O'Toole D., Laffey J. G., Mesenchymal stem cells enhance recovery and repair following ventilator-induced lung injury in the rat. Thorax 2012 67 6 496 501 10.1136/thoraxjnl-2011-201059 2-s2.0-84861868459 22106021 Thorax, vol. 67, no. 6, pp. 496â€"501, 2012.
9. Silva J. D., Lopes-Pacheco M., Paz A. H. R., Cruz F. F., Melo E. B., de Oliveira M. V., Xisto D. G., Capelozzi V. L., Morales M. M., Pelosi P., Cirne-Lima E., Rocco P. R. M., Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome. Critical Care Medicine 2018 46 2 e132 e140 10.1097/CCM.0000000000002833 29116998 Critical Care Medicine, vol. 46, no. 2, pp. e132â€"e140, 2018.
10. Mei S. H. J., Haitsma J. J., Dos Santos C. C., Deng Y., Lai P. F. H., Slutsky A. S., Liles W. C., Stewart D. J., Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. American Journal of Respiratory and Critical Care Medicine 2010 182 8 1047 1057 10.1164/rccm.201001-0010OC 2-s2.0-77956246824 20558630 American Journal of Respiratory and Critical Care Medicine, vol. 182, no. 8, pp. 1047â€"1057, 2010.
11. Maron-Gutierrez T., Silva J. D., Asensi K. D., Bakker-Abreu I., Shan Y., Diaz B. L., Goldenberg R. C. S., Mei S. H. J., Stewart D. J., Morales M. M., Rocco P. R. M., Dos Santos C. C., Effects of mesenchymal stem cell therapy on the time course of pulmonary remodeling depend on the etiology of lung injury in mice. Critical Care Medicine 2013 41 11 e319 e333 10.1097/CCM.0b013e31828a663e 2-s2.0-84887106459 Critical Care Medicine, vol. 41, no. 11, pp. e319â€"e333, 2013.
12. Gupta N., Su X., Popov B., Lee J. W., Serikov V., Matthay M. A., Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. Journal of Immunology 2007 179 3 1855 1863 10.4049/jimmunol.179.3.1855 2-s2.0-34548610480 Journal of Immunology, vol. 179, no. 3, pp. 1855â€"1863, 2007.
13. Monsel A., Zhu Y. G., Gudapati V., Lim H., Lee J. W., Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opinion on Biological Therapy 2016 16 7 859 871 10.1517/14712598.2016.1170804 2-s2.0-84963535654 27011289 Expert Opinion on Biological Therapy, vol. 16, no. 7, pp. 859â€"871, 2016.
14. Ionescu L., Byrne R. N., van Haaften T., Vadivel A., Alphonse R. S., Rey-Parra G. J., Weissmann G., Hall A., Eaton F., Thébaud B., Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. American Journal of Physiology. Lung Cellular and Molecular Physiology 2012 303 11 L967 L977 10.1152/ajplung.00144.2011 2-s2.0-84870898170 23023971 American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 303, no. 11, pp. L967â€"L977, 2012.
15. Zhu Y. G., Feng X. M., Abbott J., Fang X. H., Hao Q., Monsel A., Qu J. M., Matthay M. A., Lee J. W., Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014 32 1 116 125 10.1002/stem.1504 2-s2.0-84891819825 23939814 Stem Cells, vol. 32, no. 1, pp. 116â€"125, 2014.
16. Witwer K. W., van Balkom B. W. M., Bruno S., Choo A., Dominici M., Gimona M., Hill A. F., de Kleijn D., Koh M., Lai R. C., Mitsialis S. A., Ortiz L. A., Rohde E., Asada T., Toh W. S., Weiss D. J., Zheng L., Giebel B., Lim S. K., Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. Journal of Extracellular Vesicles 2019 8 1 10.1080/20013078.2019.1609206 Journal of Extracellular Vesicles, vol. 8, no. 1, 2019.
17. Cruz F. F., Borg Z. D., Goodwin M., Sokocevic D., Wagner D. E., Coffey A., Antunes M., Robinson K. L., Mitsialis S. A., Kourembanas S., Thane K., Hoffman A. M., McKenna D. H., Rocco P. R. M., Weiss D. J., Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates Aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice. Stem Cells Translational Medicine 2015 4 11 1302 1316 10.5966/sctm.2014-0280 2-s2.0-84945306718 Stem Cells Translational Medicine, vol. 4, no. 11, pp. 1302â€"1316, 2015.
18. Abreu S. C., Lopes-Pacheco M., da Silva A. L., Xisto D. G., de Oliveira T. B., Kitoko J. Z., de Castro L. L., Amorim N. R., Martins V., Silva L. H. A., Gonçalves-de-Albuquerque C. F., Castro Faria-Neto H. C., Olsen P. C., Weiss D. J., Morales M. M., Diaz B. L., Rocco P. R. M., Eicosapentaenoic acid enhances the effects of mesenchymal stromal cell therapy in experimental allergic asthma. Frontiers in Immunology 2018 9 1147 10.3389/fimmu.2018.01147 2-s2.0-85047470450 Frontiers in Immunology, vol. 9, p. 1147, 2018.
19. Saparov A., Ogay V., Nurgozhin T., Jumabay M., Chen W. C. W., Preconditioning of human mesenchymal stem cells to enhance their regulation of the immune response. Stem Cells Int 2016 2016, article 3924858 1 10 10.1155/2016/3924858 2-s2.0-84994796635 27822228 Stem Cells Int, vol. 2016, article 3924858, pp. 1â€"10, 2016.
20. Silva L. H. A., Antunes M. A., Dos Santos C. C., Weiss D. J., Cruz F. F., Rocco P. R. M., Strategies to improve the therapeutic effects of mesenchymal stromal cells in respiratory diseases. Stem Cell Research & Therapy 2018 9 1 45 10.1186/s13287-018-0802-8 2-s2.0-85042621979 29482654 Stem Cell Research & Therapy, vol. 9, no. 1, p. 45, 2018.
21. Abreu S. C., Xisto D. G., de Oliveira T. B., Blanco N. G., de Castro L. L., Kitoko J. Z., Olsen P. C., Lopes-Pacheco M., Morales M. M., Weiss D. J., Rocco P. R. M., Serum from asthmatic mice potentiates the therapeutic effects of mesenchymal stromal cells in experimental allergic asthma. Stem Cells Translational Medicine 2019 8 3 301 312 10.1002/sctm.18-0056 2-s2.0-85056470002 30426724 Stem Cells Translational Medicine, vol. 8, no. 3, pp. 301â€"312, 2019.
22. Pelosi P., D'Onofrio D., Chiumello D., Paolo S., Chiara G., Capelozzi V. L., Barbas C. S. V., Chiaranda M., Gattinoni L., Pulmonary and extrapulmonary acute respiratory distress syndrome are different. European Respiratory Journal 2003 22 Supplement 42 48s 56s 10.1183/09031936.03.00420803 European Respiratory Journal, vol. 22, Supplement 42, pp. 48sâ€"56s, 2003.
23. Kilkenny C., Browne W. J., Cuthill I. C., Emerson M., Altman D. G., Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biology 2010 8 6 10.1371/journal.pbio.1000412 2-s2.0-85041813459 20613859 PLoS Biology, vol. 8, no. 6, 2010.
24. Bates J. H., Ludwig M. S., Sly P. D., Brown K., Martin J. G., Fredberg J. J., Interrupter resistance elucidated by alveolar pressure measurement in open-chest normal dogs. Journal of Applied Physiology 1988 65 1 408 414 10.1152/jappl.1988.65.1.408 3042744 Journal of Applied Physiology, vol. 65, no. 1, pp. 408â€"414, 1988.
25. Silva J. D., Paredes B. D., Araújo I. M., Lopes-Pacheco M., Oliveira M. V., Suhett G. D., Faccioli L. A. P., Assis E., Castro-Faria-Neto H. C., Goldenberg R. C. S., Capelozzi V. L., Morales M. M., Pelosi P., Xisto D. G., Rocco P. R. M., Effects of bone marrow-derived mononuclear cells from healthy or acute respiratory distress syndrome donors on recipient lung-injured mice. Critical Care Medicine 2014 42 7 e510 e524 10.1097/CCM.0000000000000296 2-s2.0-84902545261 Critical Care Medicine, vol. 42, no. 7, pp. e510â€"e524, 2014.
26. Hsia C. C., Hyde D. M., Ochs M., Weibel E. R., ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure, An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. American Journal of Respiratory and Critical Care Medicine 2010 181 4 394 418 10.1164/rccm.200809-1522ST 2-s2.0-76149084817 20130146 American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 4, pp. 394â€"418, 2010.
27. Araújo I. M., Abreu S. C., Maron-Gutierrez T., Cruz F., Fujisaki L., Carreira H. Jr., Ornellas F., Ornellas D., Vieira-de-Abreu A., Castro-Faria-Neto H. C., Muxfeldt AbSaber A., Teodoro W. R., Diaz B. L., Peres DaCosta C., Capelozzi V. L., Pelosi P., Morales M. M., Rocco P. R. M., Bone marrow-derived mononuclear cell therapy in experimental pulmonary and extrapulmonary acute lung injury. Critical Care Medicine 2010 38 8 1733 1741 10.1097/CCM.0b013e3181e796d2 2-s2.0-77954953191 20562701 Critical Care Medicine, vol. 38, no. 8, pp. 1733â€"1741, 2010.
28. Hizume D. C., Rivero D. H. R. F., Kasahara D. I., Leme A. S., Arantes-Costa F. M., Olivo C. R., Sales P., Dolhnikoff M., Martins M. A., Effects of positive end-expiratory pressure in an experimental model of acute myocardial infarct in Wistar rats. Shock 2007 27 5 584 589 10.1097/01.shk.0000248594.79012.d6 2-s2.0-34247253917 17438466 Shock, vol. 27, no. 5, pp. 584â€"589, 2007.
29. Maron-Gutierrez T., Silva J., Cruz F., Alegria S., Xisto D., Assis E., Castro-Faria-Neto H., Santos C. C., Morales M., Rocco P. R., Insult-dependent effect of bone marrow cell therapy on inflammatory response in a murine model of extrapulmonary acute respiratory distress syndrome. Stem Cell Research & Therapy 2013 4 5 123 10.1186/scrt334 2-s2.0-84885354468 Stem Cell Research & Therapy, vol. 4, no. 5, p. 123, 2013.
30. Zhang X., Goncalves R., Mosser D. M., The isolation and characterization of murine macrophages. Current Protocols in Immunology 2008 83 10.1002/0471142735.im1401s83 2-s2.0-58849167699 Current Protocols in Immunology, vol. 83, 2008.
31. Santos F. B., Nagato L. K. S., Boechem N. M., Negri E. M., Guimarães A., Capelozzi V. L., Faffe D. S., Zin W. A., Rocco P. R. M., Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. Journal of Applied Physiology 2006 100 1 98 106 10.1152/japplphysiol.00395.2005 2-s2.0-33644828491 Journal of Applied Physiology, vol. 100, no. 1, pp. 98â€"106, 2006.
32. Menezes S. L. S., Bozza P. T., Faria Neto H. C. C., Laranjeira A. P., Negri E. M., Capelozzi V. L., Zin W. A., Rocco P. R. M., Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. Journal of Applied Physiology 2005 98 5 1777 1783 10.1152/japplphysiol.01182.2004 2-s2.0-17644390228 Journal of Applied Physiology, vol. 98, no. 5, pp. 1777â€"1783, 2005.
33. Xu J., Woods C. R., Mora A. L., Joodi R., Brigham K. L., Iyer S., Rojas M., Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 2007 293 1 L131 L141 10.1152/ajplung.00431.2006 2-s2.0-34447511526 17416739 American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 293, no. 1, pp. L131â€"L141, 2007.
34. Krasnodembskaya A., Samarani G., Song Y., Zhuo H., Su X., Lee J. W., Gupta N., Petrini M., Matthay M. A., Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. American Journal of Physiology. Lung Cellular and Molecular Physiology 2012 302 10 L1003 L1013 10.1152/ajplung.00180.2011 2-s2.0-84861162374 American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 302, no. 10, pp. L1003â€"L1013, 2012.
35. Li J. W., Wu X., Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells. European Review for Medical and Pharmacological Sciences 2015 19 2368 2378 European Review for Medical and Pharmacological Sciences, vol. 19, pp. 2368â€"2378, 2015.
36. Lee J. W., Fang X., Gupta N., Serikov V., Matthay M. A., Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences 2009 106 38 16357 16362 10.1073/pnas.0907996106 2-s2.0-70349392958 19721001 Proceedings of the National Academy of Sciences, vol. 106, no. 38, pp. 16357â€"16362, 2009.
37. Luo C. J., Zhang F. J., Zhang L., Geng Y. Q., Li Q. G., Hong Q., Fu B., Zhu F., Cui S. Y., Feng Z., Sun X. F., Chen X. M., Mesenchymal stem cells ameliorate sepsis-Associated acute kidney injury in mice. Shock 2014 41 2 123 129 10.1097/SHK.0000000000000080 2-s2.0-84893412493 Shock, vol. 41, no. 2, pp. 123â€"129, 2014.
38. McIntyre L. A., Moher D., Fergusson D. A., Sullivan K. J., Mei S. H. J., Lalu M., Marshall J., Mcleod M., Griffin G., Grimshaw J., Turgeon A., Avey M. T., Rudnicki M. A., Jazi M., Fishman J., Stewart D. J., Canadian Critical Care Translational Biology Group, Efficacy of mesenchymal stromal cell therapy for acute lung injury in preclinical animal models: A systematic review. PLoS One 2016 11 1, article e0147170 10.1371/journal.pone.0147170 2-s2.0-84959036595 26821255 PLoS One, vol. 11, no. 1, article e0147170, 2016.
39. Wilson J. G., Liu K. D., Zhuo H., Caballero L., McMillan M., Fang X., Cosgrove K., Vojnik R., Calfee C. S., Lee J. W., Rogers A. J., Levitt J., Wiener-Kronish J., Bajwa E. K., Leavitt A., McKenna D., Thompson B. T., Matthay M. A., Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. The Lancet Respiratory Medicine 2015 3 1 24 32 10.1016/S2213-2600(14)70291-7 2-s2.0-84920500515 The Lancet Respiratory Medicine, vol. 3, no. 1, pp. 24â€"32, 2015.
40. Matthay M. A., Calfee C. S., Zhuo H., Thompson B. T., Wilson J. G., Levitt J. E., Rogers A. J., Gotts J. E., Wiener-Kronish J. P., Bajwa E. K., Donahoe M. P., McVerry B. J., Ortiz L. A., Exline M., Christman J. W., Abbott J., Delucchi K. L., Caballero L., McMillan M., McKenna D. H., Liu K. D., Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): A randomised phase 2a safety trial. The Lancet Respiratory Medicine 2019 7 2 154 162 10.1016/S2213-2600(18)30418-1 2-s2.0-85060547818 The Lancet Respiratory Medicine, vol. 7, no. 2, pp. 154â€"162, 2019.
41. Deng J. C., Standiford T. J., Growth factors and cytokines in acute lung injury. Comprehensive Physiology 2011 1 1 81 104 10.1002/cphy.c090011 2-s2.0-84861976694 23737165 Comprehensive Physiology, vol. 1, no. 1, pp. 81â€"104, 2011.
42. Bhatia M., Moochhala S., Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 2004 202 2 145 156 10.1002/path.1491 2-s2.0-1142299409 The Journal of Pathology, vol. 202, no. 2, pp. 145â€"156, 2004.
43. Lopes-Pacheco M., Bandeira E., Morales M. M., Cell-based therapy for silicosis. Stem Cells Int 2016 2016, article 5091838 1 9 10.1155/2016/5091838 2-s2.0-84971249919 27066079 Stem Cells Int, vol. 2016, article 5091838, pp. 1â€"9, 2016.
44. Pittet J. F., Griffiths M. J. D., Geiser T., Kaminski N., Dalton S. L., Huang X., Brown L. A. S., Gotwals P. J., Koteliansky V. E., Matthay M. A., Sheppard D., TGF-beta is a critical mediator of acute lung injury. The Journal of Clinical Investigation 2001 107 12 1537 1544 10.1172/JCI11963 2-s2.0-0034977190 11413161 The Journal of Clinical Investigation, vol. 107, no. 12, pp. 1537â€"1544, 2001.
45. Thickett D. R., Armstrong L., Christie S. J., Millar A. B., Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2001 164 9 1601 1605 10.1164/ajrccm.164.9.2011071 2-s2.0-0035509116 11719296 American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 9, pp. 1601â€"1605, 2001.
46. Lopes-Pacheco M., Ventura T. G., de Oliveira H. D.'. A., Monção-Ribeiro L. C., Gutfilen B., de Souza S. A. L., Rocco P. R. M., Borojevic R., Morales M. M., Takiya C. M., Infusion of bone marrow mononuclear cells reduced lung fibrosis but not inflammation in the late stages of murine silicosis. PLoS One 2014 9 10 10.1371/journal.pone.0109982 2-s2.0-84907822189 25299237 PLoS One, vol. 9, no. 10, 2014.
47. Chiossone L., Conte R., Spaggiari G. M., Serra M., Romei C., Bellora F., Becchetti F., Andaloro A., Moretta L., Bottino C., Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses. Stem Cells 2016 34 7 1909 1921 10.1002/stem.2369 2-s2.0-84979032272 Stem Cells, vol. 34, no. 7, pp. 1909â€"1921, 2016.
48. Nemeth K., Keane-Myers A., Brown J. M., Metcalfe D. D., Gorham J. D., Bundoc V. G., Hodges M. G., Jelinek I., Madala S., Karpati S., Mezey E., Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma. Proceedings of the National Academy of Sciences of the United States of America 2010 107 12 5652 5657 10.1073/pnas.0910720107 2-s2.0-77950377767 20231466 Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5652â€"5657, 2010.